L

Laura A. VanBlargan

National Institutes of Health

ORCID: 0000-0002-8922-8946

Publishes on SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Mosquito-borne diseases and control. 71 papers and 7.8k citations.

71Publications

7.8kTotal Citations

SARS-CoV-2 and COVID-19 Research COVID-19 Clinical Research Studies Mosquito-borne diseases and control SARS-CoV-2 detection and testing Animal Virus Infections Studies

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift

Elisabetta Cameroni, John E. Bowen, Laura E. Rosen et al.|Nature|2021

Cited by 1.2kOpen Access

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Rita E. Chen, Xianwen Zhang, James Brett Case et al.|Nature Medicine|2021

Cited by 1kOpen Access

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Zhuoming Liu, Laura A. VanBlargan, Louis-Marie Bloyet et al.|Cell Host & Microbe|2021

Cited by 847Open Access

An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies

Laura A. VanBlargan, John M. Errico, Peter Halfmann et al.|Nature Medicine|2022

Cited by 764Open Access

A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2

Ahmed O. Hassan, Natasha M. Kafai, Igor P. Dmitriev et al.|Cell|2020

Cited by 624Open Access